Validation of a screener and opioid assessment measure for patients with chronic pain - PubMed (original) (raw)
Comparative Study
. 2004 Nov;112(1-2):65-75.
doi: 10.1016/j.pain.2004.07.026.
Affiliations
- PMID: 15494186
- DOI: 10.1016/j.pain.2004.07.026
Comparative Study
Validation of a screener and opioid assessment measure for patients with chronic pain
Stephen F Butler et al. Pain. 2004 Nov.
Abstract
There has been a need for a brief assessment tool for providers who treat chronic pain patients to determine potential risk of abuse when prescribed opioids for pain. The purpose of this study was to develop and begin the validation of a self-administered screening tool (Screener and Opioid Assessment for Patients with Pain, SOAPP) for chronic pain patients considered for long-term opioid therapy. A consensus of 26 pain and addiction experts was obtained on important characteristics of chronic pain patients that predict future medication misuse using concept mapping. A 24-item SOAPP (version 1.0) was developed based on this consensus and was administered to 175 patients who were taking opioids for chronic pain. After 6 months, 95 of these patients were re-evaluated. Validation of the SOAPP was conducted by identifying those patients exhibiting aberrant drug-related behavior as determined by any of the following: a positive score on the Prescription Drug Use Questionnaire (PDUQ) interview, positive urine toxicology screen, and/or ratings by staff as to whether patients had a serious drug problem. Of the original 24 items, 14 SOAPP items appeared to predict subsequent aberrant behaviors. Coefficient alpha for these 14 items was acceptable for a short scale (0.74). Receiver operating characteristics curve analysis yielded an area under the curve of 0.881 (P<0.001), suggesting adequate sensitivity and specificity for a screening device. These reliability and predictive validity results suggest that the SOAPP is a promising step toward screening risk potential for substance misuse among persons with chronic pain.
Similar articles
- Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Wasan AD, et al. Clin J Pain. 2007 May;23(4):307-15. doi: 10.1097/AJP.0b013e3180330dc5. Clin J Pain. 2007. PMID: 17449991 - Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).
Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Akbik H, et al. J Pain Symptom Manage. 2006 Sep;32(3):287-93. doi: 10.1016/j.jpainsymman.2006.03.010. J Pain Symptom Manage. 2006. PMID: 16939853 Clinical Trial. - A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
Moore TM, Jones T, Browder JH, Daffron S, Passik SD. Moore TM, et al. Pain Med. 2009 Nov;10(8):1426-33. doi: 10.1111/j.1526-4637.2009.00743.x. Pain Med. 2009. PMID: 20021601
Cited by
- Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders.
Chamoun K, Mouawad J, Salameh P, Sacre H, Haddad R, Khabbaz LR, Megarbane B, Hajj A. Chamoun K, et al. BMC Psychiatry. 2023 Nov 1;23(1):797. doi: 10.1186/s12888-023-05304-8. BMC Psychiatry. 2023. PMID: 37914993 Free PMC article. - Effect and safety of listening to music or audiobooks as a coadjuvant treatment for chronic pain patients under opioid treatment: a study protocol for an open-label, parallel-group, randomised, controlled, proof-of-concept clinical trial in a tertiary hospital in the Barcelona South Metropolitan area.
Grau-Sánchez J, Serrano A, Villoria J, Carnaval T, Porto MF, Zapata L, Flores-García M, Segura E, Garrido-Pedrosa J, Rodríguez-Fornells A, Fernández-Dueñas V, Videla S. Grau-Sánchez J, et al. BMJ Open. 2023 Sep 11;13(9):e074948. doi: 10.1136/bmjopen-2023-074948. BMJ Open. 2023. PMID: 37696633 Free PMC article. - Cannabis use preferences in women with myofascial pelvic pain: A cross-sectional study.
Yang EC, Koenig NA, Gong M, Brotto LA, Barr AM, Lee T, Yong PJ, Geoffrion R. Yang EC, et al. Eur J Obstet Gynecol Reprod Biol X. 2023 Mar 30;18:100192. doi: 10.1016/j.eurox.2023.100192. eCollection 2023 Jun. Eur J Obstet Gynecol Reprod Biol X. 2023. PMID: 37095765 Free PMC article. - Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham JA, Markovic T, Massaly N, Morón JA. Higginbotham JA, et al. Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022. Front Syst Neurosci. 2022. PMID: 36341476 Free PMC article. Review. - Learning from addiction: Craving of prescription opioids in chronic pain sufferers.
Strigo IA, Murphy E, Mitchell JM, Spadoni AD. Strigo IA, et al. Neurosci Biobehav Rev. 2022 Nov;142:104904. doi: 10.1016/j.neubiorev.2022.104904. Epub 2022 Oct 4. Neurosci Biobehav Rev. 2022. PMID: 36202255 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical